N-methyl-d-aspartate receptor (NMDAR) is an essential target for ethanol action in the central nervous system (CNS). Whereas an alcohol addiction treatment represents a severe medical problem, many aspects of ethanol action at physiologically relevant concentrations on NMDARs are still unclear. Here using the whole-cell patch-clamp recording on cortical neurons in the primary culture, we studied inhibition of NMDAR currents by different ethanol concentrations ([Et]s) and its dependence on extracellular Ca. The ethanol action on NMDA-activated currents exhibited a biphasic concentration-inhibition relationship in the presence of extracellular Ca. The high-affinity region of the curve was found within the range of [Et]s from 9 mM to 30 mM and was characterized by IC of about 20 mM. The low-affinity region was observed within the range of [Et]s from 85 mM to 200 mM with IC of about 150 mM. In the absence of extracellular Ca, the ethanol concentration-inhibition relationship became monophasic, with IC of about 200 mM, since the high-affinity component disappeared. A substitution of Li for Na in the bathing solution and an extraction of cholesterol from the plasma membrane with methyl-β-cyclodextrin, which are the treatments that both promote the Ca-dependent desensitization (CDD) of NMDARs, abolished the high-affinity Ca-dependent component of the NMDAR ethanol inhibition. Besides, this component was not observed when neurons were loaded with BAPTA. These data suggest that most likely, ethanol at low concentrations enhances the NMDAR CDD. In agreement when the dependence of the NMDAR CDD on extracellular Ca was directly measured 22 mM ethanol enhanced the NMDAR CDD since an extracellular Ca concentration that caused 50% of the NMDAR CDD decreased almost 3-folds from 0.81 mM to 0.28 mM, and an extent of the CDD was also more pronounced. The low-affinity component of the NMDAR ethanol inhibition was resistant to the above treatments suggesting CDD-independent direct action on NMDARs. Thus, at a physiologically relevant concentration of extracellular Ca and ethanol that could be reached in the blood during light-mild human alcohol intoxication, ethanol causes an enhancement of the NMDAR CDD, which could be in general accompanied by some disruptions of the CNS excitatory system.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2019.12.007DOI Listing

Publication Analysis

Top Keywords

nmdar cdd
20
ethanol
12
ethanol inhibition
12
ethanol action
12
extracellular ethanol
12
nmdar
9
physiologically relevant
8
concentration-inhibition relationship
8
range [et]s
8
component nmdar
8

Similar Publications

The open-channel block of -methyl-D-aspartate receptors (NMDARs) and their calcium-dependent desensitization (CDD) represent conventional mechanisms of glutamatergic synapse regulation. In neurotrauma, neurodegeneration, and neuropathic pain the clinical benefits of cure with memantine, ketamine, Mg, and some tricyclic antidepressants are often attributed to NMDAR open-channel block, while possible involvement of NMDAR CDD in the therapy is not well established. Here the effects of selective high-affinity sodium-calcium exchanger (NCX) isoform 1 inhibitor, SEA0400, on NMDA-activated whole-cell currents and their block by amitriptyline, desipramine and clomipramine recorded by patch-clamp technique in cortical neurons of primary culture were studied.

View Article and Find Full Text PDF
Article Synopsis
  • Mutations in the CDKL5 gene, associated with severe neurological disorders, lead to issues like early-onset epilepsy, autism, and intellectual disability, prompting this study to explore their impact on hippocampal function.
  • Using a rat model with a specific loss of function mutation, the researchers conducted various electrophysiological and biochemical assessments to understand how the absence of CDKL5 affects synaptic behavior in the brain.
  • The findings revealed enhanced long-term potentiation in juvenile Cdkl5 rats without altering NMDA receptor function or silent synapse formation, suggesting CDKL5 plays a crucial role in maintaining normal synaptic plasticity in the hippocampus.
View Article and Find Full Text PDF

The facilitated activity of N-methyl-D-aspartate receptors (NMDARs) in the central and peripheral nervous systems promotes neuropathic pain. Amitriptyline (ATL) and desipramine (DES) are tricyclic antidepressants (TCAs) whose anti-NMDAR properties contribute to their analgetic effects. At therapeutic concentrations <1 µM, these medicines inhibit NMDARs by enhancing their calcium-dependent desensitization (CDD).

View Article and Find Full Text PDF

Background: encodes Dexamethasone-induced Ras-related protein 1 (Dexras1), a protein with a critical role in signal transduction in neurons. There is a strong suspicion that dysfunction of Dexras1 might contribute to the pathogenesis of neuropsychiatric diseases. Related to its functions in intracellular signaling pathways, Dexras1 has a potential role in the etiology of schizophrenia because of its close interaction with NOS1, NOS1AP, and NMDAR, which have previously been associated with schizophrenia.

View Article and Find Full Text PDF

It is known that overexpression of -methyl-D-aspartate receptors (NMDARs) contributes to central sensitization and development of neuropathic pain. Tricyclic antidepressants (TCAs), amitriptyline (ATL), and desipramine (DES) exhibit analgetic anti-NMDAR activity and are commonly utilized for pain therapy. This property is determined by their ability to enhance the calcium-dependent desensitization (CDD) of NMDARs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!